We are live on ! Find out more
PHGE icon

BiomX
PHGE

14 hedge funds and large institutions have $2.1M invested in BiomX in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding

Funds holding: 10 → 14 (+4)

0% less ownership

Funds ownership: 0.11% → 0.11% (-0%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

54% less capital invested

Capital invested by funds: $4.51M → $2.1M (-$2.42M)

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
–
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$46.1K
2
Jane Street
Jane Street
New York
+$25.1K
3
Citadel Advisors
Citadel Advisors
Florida
+$21.4K
4
Walleye Capital
Walleye Capital
New York
+$9.05K
5
Walleye Trading
Walleye Trading
New York
+$7.01K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$114K
2
Renaissance Technologies
Renaissance Technologies
New York
-$8.03K
3
UBS Group
UBS Group
Switzerland
-$4.59K

PHGE Hedge Fund Activity: Q3 2022 in Review

14 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q3 2022, worth a combined $2.1M — down 54% from $4.51M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PHGE positions and 0 closed out — a net gain of 4 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $46.1K. The largest seller was Royce & Associates, cutting an estimated $114K.

  • 14 institutional investors held BiomX (PHGE) as of Q3 2022, up from 10 in Q2 2022.
  • Funds reported $2.1M of BiomX stock for Q3 2022, down 54% quarter-over-quarter.
  • 4 funds opened new BiomX positions in Q3 2022 and 0 closed out, a net change of +4 holders.
  • The largest BiomX buyer in Q3 2022 was Virtu Financial, an estimated $46.1K added.
  • The largest BiomX seller in Q3 2022 was Royce & Associates, an estimated $114K sold.

Based on aggregated 13F filings for Q3 2022.